Clinical Trials Logo

Reperfusion Injury clinical trials

View clinical trials related to Reperfusion Injury.

Filter by:

NCT ID: NCT02812901 Completed - Myocardial Ischemia Clinical Trials

Tolerance of Myocardium to Ischemia Injury

TOMIS
Start date: January 2016
Phase: N/A
Study type: Interventional

This study aims to understand the impact of time-of-the day on human myocardial tolerance to ischemia-reperfusion by exploring atrial myocardium biopsied during cardiac surgery. Patients scheduled for non-urgent cardiac surgery (coronary artery by-pas graft and/or aortic valve replacement) will be assigned to a morning or an afternoon cardiac surgery based on randomization. Myocardial biopsies will be explored in ex vivo conditions mimicking ischemia-reperfusion.

NCT ID: NCT02807727 Recruiting - Reperfusion Injury Clinical Trials

Cardiac REperfusion With Intralipid® at Reperfusion

CREW-I
Start date: January 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This study will evaluate the benefit of Intralipid® or placebo administered prior to reperfusion to limit ischemia reperfusion injury as measured by the geometric mean difference of the release of troponin I over 72 hours after coronary artery bypass.

NCT ID: NCT02731651 Completed - Reperfusion Injury Clinical Trials

Effect of Pneumoperitoneum on Human Ovary

Start date: October 2014
Phase: N/A
Study type: Interventional

Laparoscopic surgery has played a pivotal role in all surgical fields in modern medicine. It has some well known advantages over open surgery. For this reason laparoscopic surgery is know the first choice for many surgical procedures, even in gynecology. On the other hand, despite the advantages of laparoscopy carbon dioxide (CO2) pneumoperitoneum is not free from side effects. Experimental studies and limited clinical studies showed that pneumoperitoneum leads to a decrease in the blood flow to intra-abdominal organs during laparoscopic surgery. This is also known as ischemia, leads to the production of free O2 radicals. The desufflation of the abdominal cavity at the end of the procedure reduces the increased abdominal pressure and increase the perfusion of intra-abdominal organs. However this will not stop the production of free radicals. This reperfusion period even exaggerate the release of free radicals. This phenomenon is called as ischemia/reperfusion (I/R) model that leads to release of various free radicals, which are the most important mediators of oxidative tissue injury and consequential organ dysfunction. Recently both oxidative tissue injury and consequential dysfunction have been shown in ovarian tissue in experimental animal studies. But the data related to human ovary is still scarce. Thus the aim of the study is to evaluate the effect of I/R injury related to CO2 pneumoperitoneum on human ovary.

NCT ID: NCT02729155 Recruiting - Clinical trials for Ischemic Reperfusion Injury

Single-cycle Remote Ischemic Preconditioning and Postconditioning for Prevention of Contrast-Induced Nephropathy

Start date: October 2015
Phase: N/A
Study type: Interventional

This trial is a 2 x 2 factorial design, double-blinded, randomized controlled trial to evaluate efficacy and safety of remote ischemic preconditioning and postconditioning for prevention of contrast-induced acute kidney injury in patient undergoing coronary angiography and angioplasty

NCT ID: NCT02709798 Completed - Clinical trials for Myocardial Infarction

ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction

SF-STEMI
Start date: April 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate whether perioperative use of Shenfu Injection could reduce myocardial injury (enzymatic infarct size and infarct volume according to cardiac magnetic resonance imaging) in patients with STEMI after primary PCI

NCT ID: NCT02649309 Recruiting - Clinical trials for Ischemic Reperfusion Injury

Single-cycle Remote Ischemic Preconditioning and Postconditioning (SCRIP) Trial

SCRIP
Start date: October 2015
Phase: N/A
Study type: Interventional

This trial is a 2 x 2 factorial design, double-blinded, randomized controlled trial to evaluate efficacy and safety of remote ischemic preconditioning and postconditioning in patient undergoing coronary angioplasty.

NCT ID: NCT02648958 Completed - Clinical trials for Arthroplasty, Replacement

Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Lower Extremity Operations

Start date: January 2016
Phase: N/A
Study type: Interventional

Ischemia reperfusion injury causes the release of free oxygen radicals. The selective alpha2-receptor agonist, dexmedetomidine, has an inhibitory effect on inflammatory responses during ischemic injury. The aim of this study is to evaluate the effect of dexmedetomidine on inflammatory responses during ischemia-reperfusion injury in skeletal muscle.

NCT ID: NCT02581618 Completed - Myocardial Ischemia Clinical Trials

Remote Ischemic Preconditioning in Elective Percutaneous Interventions

Start date: May 2015
Phase: N/A
Study type: Interventional

Myocardial injury occurs after percutaneous coronary intervention due to micro emboli, ischemia-reperfusion injury or side branch occlusion. 3 cycles of ischemic preconditioning has been shown to be useful in preventing myocardial injury but it is not suitable to perform it especially in ad hoc interventions. In this study the investigators aim is to show whether one cycle remote ischemic preconditioning will be enough to prevent myocardial injury during percutaneous coronary intervention.

NCT ID: NCT02568696 Active, not recruiting - Clinical trials for End Stage Renal Disease

Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft Function

KTX
Start date: June 2015
Phase:
Study type: Observational

The purpose of this study is to investigate local activation of the coagulation system in the kidney graft during organ preservation and during early reperfusion in adult kidney transplantation. Generation of thrombin and fibrin as well as activation and inhibition of fibrinolysis will be investigated. Influence of these events on delayed graft function (DGF) and acute cell-mediated rejection will be evaluated.

NCT ID: NCT02540447 Completed - Clinical trials for Ischemia Reperfusion Injury

Purge Vs no Purge in Living Donor Liver Transplantation Recipients

PNP
Start date: January 2013
Phase: N/A
Study type: Interventional

The investigators tested the impact of purging the graft contents and mesenteric blood into the systemic circulation versus washing out this volume out of the circulation in living donor liver transplantation recipients.